Column Group IV GP, LP

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-39.0%

median move per position

+7.4%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$38.12M bought

All filings on record

Every Form 4 transaction we track for this filer

All10Buys3Sells0

Stock	Transaction	Date	~6mo vs S&P
EIKNEikon Therapeutics, Inc.	Buy $11.36M · 630,881 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Buy $892.0K · 49,556 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Buy $25.87M · 1,437,323 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 688,283 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 3,785 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 47,898 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 44,249 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 110,928 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 1,403,568 sh	2026-02-06	—
EIKNEikon Therapeutics, Inc.	Convert — · 1,296,629 sh	2026-02-06	—

EIKNBuy

2026-02-06 · Eikon Therapeutics, Inc.

$11.36M

—

EIKNBuy

2026-02-06 · Eikon Therapeutics, Inc.

$892.0K

—

EIKNBuy

2026-02-06 · Eikon Therapeutics, Inc.

$25.87M

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

688,283

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

3,785

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

47,898

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

44,249

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

110,928

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

1,403,568

—

EIKNConvert

2026-02-06 · Eikon Therapeutics, Inc.

1,296,629

—

10 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

LV

Lux Venture Partners V, LLC

EIKN · last 2026-02-06

PR

Perlmutter Roger M

EIKN · last 2026-02-06

WJ

Wolfe Josh

EIKN · last 2026-02-06

FC

Foresite Capital Management IV, LLC

EIKN · last 2026-02-04

FK

Frazier Kenneth C

EIKN · last 2026-02-04

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.